| Date YYYY-MM-DD |
Board Meeting | Decision Point Number | Title |
|---|---|---|---|
| 2021-05-11 | B45 | GF/B45/DP01 |
Appointment of the Rapporteur Appointment of the Rapporteur
<p>Birgit Pickel from the Germany Constituency is designated as Rapporteur for the 45th Board Meeting.</p>
|
| 2021-05-11 | B45 | GF/B45/DP02 |
Approval of the Agenda Approval of the Agenda
<p>The agenda for the 45th Board Meeting (GF/B45/01) is approved.</p>
|
| 2021-05-11 | B45 | GF/B45/DP03 |
Operating Expenses for the 2020-2022 Allocation Period Operating Expenses for the 2020-2022 Allocation Period
<p>Based on the recommendation of the Audit and Finance Committee, the Board approves the increase of forecasted aggregate operating expenses available for the 2020-2022 allocation period by US$ 30 million, in order to facilitate the implementation of critical activities in 2022; such that the amount made available for operating expenses for the 2020-2022 allocation cycle shall be US$ 930 million.</p>
|
| 2021-06-04 | B45 | GF/B45/EDP01 |
Approval of Revised Definitions, Metric Adjustments and Targets for KPIs Approval of Revised Definitions, Metric Adjustments and Targets for KPIs
<p>a) Based on the recommendation of the Strategy Committee, the Board approves the revisions for Key Performance Indicators 2, 5c, 6e, 9c and 11 as presented in GF/B45/ER01.</p>
<p>b) Based on the recommendation of the Audit and Finance Committee, the Board approves the revision for Key Performance Indicator 7a as presented in GF/B45/ER01.</p>
|
| 2021-06-01 | B45 | GF/B45/EDP02 |
Revisions to the Terms of Reference of the Ethics Officer Revisions to the Terms of Reference of the Ethics Officer
<ol>
<li>The Board recalls its ultimate ownership over the Ethics and Integrity Framework and its authority to appoint the next Global Fund Ethics Officer.</li>
<li>Based on the recommendation of the Ethics and Governance Committee, the Board approves revisions to the Terms of Reference of the Ethics Officer, as set forth in Annex 1 to document GF/B45/ER02.</li>
<li>The Board acknowledges that this decision point and the revisions to the Terms of Reference of the Ethics Officer shall supersede the approval of the previous Terms of Reference of the Ethics Officer, as set forth in Annex 1 to GF/B33/ER08 and pursuant to decision point GF/B33/EDP14 (July 2015).</li>
<li>Accordingly, the Board instructs the Secretariat to launch the recruitment process to engage the next Global Fund Ethics Officer for appointment by the Board on a no-objection basis, following the joint recommendation of the EGC and the Executive Director.</li>
</ol>
|
| 2021-06-17 | B45 | GF/B45/EDP03 |
Decision on the Secretariat’s Recommendation on Funding from the 2020-2022 Allocation Decision on the Secretariat’s Recommendation on Funding from the 2020-2022 Allocation
<p>The Board:</p>
<ol>
<li>Approves the funding recommended for each country disease component, and its constituent grants, as listed in Tables 1a and 1b of GF/B45/ER03 (“Tables 1a and 1b”);</li>
<li>Acknowledges each country disease component’s constituent grants will be implemented by the proposed Principal Recipients listed in Tables 1a and 1b, or any other Principal Recipient(s) deemed appropriate by the Secretariat in accordance with Global Fund policies;</li>
<li>Affirms the funding approved under this decision (a) is subject to the availability of funding, and (b) shall be committed in annual tranches; and</li>
<li>Delegates to the Secretariat authority to redistribute the overall upper-ceiling of funding available for each country disease component among its constituent grants, provided that the Technical Review Panel (the “TRP”) validates any redistribution that constitutes a material change from the program and funding request initially reviewed and recommended by the TRP.</li>
</ol>
|
| 2021-07-01 | B45 | GF/B45/EDP04 |
Approval of the Secretariat’s Recommendation on Funding from the COVID-19 Response Mechanism (Uganda) Approval of the Secretariat’s Recommendation on Funding from the COVID-19 Response Mechanism (Uganda)
<p>The Board:</p>
<ol>
<li>Notes its decision in GF/B44/EDP18, which requires the Secretariat to recommend to the Board, for its approval, any COVID-19 Response Mechanism (“C19RM”) awards exceeding USD 35 million, as measured in aggregate by country (not including any funding awarded for COVID-19 commodities through fast-track investments or C19RM funding awarded in 2020);</li>
<li>Approves the funding recommended for each country, as listed in Table 1 of GF/B44/ER04; and</li>
<li>Delegates to the Secretariat authority to redistribute the overall upper-ceiling of funding available for each country among its constituent grants in accordance with the previously approved principles under GF/B44/EDP18.</li>
</ol>
|
| 2021-07-13 | B45 | GF/B45/EDP05 |
Decision on the Secretariat’s Recommendation on Funding from the 2020-2022 Allocation Decision on the Secretariat’s Recommendation on Funding from the 2020-2022 Allocation
<p style="text-align: justify;" class="Default">The Board:</p>
<ol>
<li class="Default" style="text-align: justify;"><span style="font-size: 11.0pt; color: windowtext;">Approves the funding recommended for each country disease component, and its constituent grants, as listed in Table 1 of GF/B45/ER05 (“Table 1”); </span></li>
<li class="Default" style="text-align: justify;"><span style="font-size: 11.0pt; color: windowtext;">Acknowledges each country disease component’s constituent grants will be implemented by the proposed Principal Recipients listed in Table 1, or any other Principal Recipient(s) deemed appropriate by the Secretariat in accordance with Global Fund policies; </span></li>
<li class="Default" style="text-align: justify;"><span style="font-size: 11.0pt; color: windowtext;">Affirms the funding approved under this decision (a) is subject to the availability of funding, and (b) shall be committed in annual tranches; and </span></li>
<li class="Default" style="text-align: justify;"><span style="font-size: 11.0pt; color: windowtext;">Delegates to the Secretariat authority to redistribute the overall upper-ceiling of funding available for each country disease component among its constituent grants, provided that the Technical Review Panel (the “TRP”) validates any redistribution that constitutes a material change from the program and funding request initially reviewed and recommended by the TRP. </span></li>
</ol>
|
| 2021-07-09 | B45 | GF/B45/EDP06 |
Approval of the Secretariat’s Recommendation on Funding from the COVID-19 Response Mechanism (Ethiopia and Malawi) Approval of the Secretariat’s Recommendation on Funding from the COVID-19 Response Mechanism (Ethiopia and Malawi)
<p>The Board:</p>
<ol>
<li>Notes its decision in GF/B44/EDP18, which requires the Secretariat to recommend to the Board, for its approval, any COVID-19 Response Mechanism (“C19RM”) awards exceeding USD 35 million, as measured in aggregate by country (not including any funding awarded for COVID-19 commodities through fast-track investments or C19RM funding awarded in 2020);</li>
<li>Approves the funding recommended for each country, as listed in Table 1 of GF/B44/ER06; and</li>
<li>Delegates to the Secretariat authority to redistribute the overall upper ceiling of funding available for each country among its constituent grants in accordance with the previously approved principles under GF/B44/EDP18.</li>
</ol>
|
| 2021-07-21 | B45 | GF/B45/EDP07 |
Approval of the Report of the Global Fund 45th Board Meeting Approval of the Report of the Global Fund 45th Board Meeting
<p>The Board approves the Report of the 45th Board Meeting, as set forth in GF/B45/22.</p>
|
| 2021-07-20 | B45 | GF/B45/EDP08 |
Approval of the Secretariat’s Recommendation on Funding from the COVID-19 Response Mechanism (Ghana and Kenya) Approval of the Secretariat’s Recommendation on Funding from the COVID-19 Response Mechanism (Ghana and Kenya)
<p>The Board:</p>
<ol>
<li>Notes its decision in GF/B44/EDP18, which requires the Secretariat to recommend to the Board, for its approval, any COVID-19 Response Mechanism (“C19RM”) awards exceeding US$35 million, as measured in aggregate by country (not including any funding awarded for COVID-19 commodities through fast-track investments or C19RM funding awarded in 2020);</li>
<li>Approves the funding recommended for each country, as listed in Table 1 of GF/B44/ER07; and</li>
<li>Delegates to the Secretariat authority to redistribute the overall upper-ceiling of funding available for each country among its constituent grants in accordance with the previously approved principles under GF/B44/EDP18.</li>
</ol>
|
| 2021-07-27 | B45 | GF/B45/EDP09 |
Approval of the Secretariat’s Recommendation on Funding from the COVID-19 Response Mechanism (Sudan and Tanzania) Approval of the Secretariat’s Recommendation on Funding from the COVID-19 Response Mechanism (Sudan and Tanzania)
<p>The Board:</p>
<ol>
<li>Notes its decision in GF/B44/EDP18, which requires the Secretariat to recommend to the Board, for its approval, any COVID-19 Response Mechanism (“C19RM”) awards exceeding US$35 million, as measured in aggregate by country (not including any funding awarded for COVID-19 commodities through fast-track investments or C19RM funding awarded in 2020);</li>
<li>Approves the funding recommended for each country, as listed in Table 1 of GF/B44/ER08; and</li>
<li>Delegates to the Secretariat authority to redistribute the overall upper-ceiling of funding available for each country among its constituent grants in accordance with the previously approved principles under GF/B44/EDP18.</li>
</ol>
|
| 2021-08-10 | B45 | GF/B45/EDP11 |
Decision on the Secretariat’s Recommendation on Funding from the 2020-2022 Allocation (Armenia, Eswatini, Guatemala and Multicountry Southern Africa TIMS) Decision on the Secretariat’s Recommendation on Funding from the 2020-2022 Allocation (Armenia, Eswatini, Guatemala and Multicountry Southern Africa TIMS)
<p>The Board:</p>
<ol>
<li>Approves the funding recommended for each country disease component, and its constituent grants, as listed in Table 1 of GF/B45/ER10 (“Table 1”);</li>
<li>Acknowledges each country disease component’s constituent grants will be implemented by the proposed Principal Recipients listed in Table 1, or any other Principal Recipient(s) deemed appropriate by the Secretariat in accordance with Global Fund policies;</li>
<li>Affirms the funding approved under this decision (a) is subject to the availability of funding, and (b) shall be committed in annual tranches; and</li>
<li>Delegates to the Secretariat authority to redistribute the overall upper-ceiling of funding available for each country disease component among its constituent grants, provided that the Technical Review Panel (the “TRP”) validates any redistribution that constitutes a material change from the program and funding request initially reviewed and recommended by the TRP.</li>
</ol>
|
| 2021-08-18 | B45 | GF/B45/EDP12 |
Increases to the COVID-19 Response Mechanism’s (C19RM) Fast-track Investment Ceiling Increases to the COVID-19 Response Mechanism’s (C19RM) Fast-track Investment Ceiling
<p>Based on the rationale provided in GF/B45/ER11, the Board delegates authority to the Audit and Finance Committee (the “AFC”) to increase the overall ceiling amount to be made available through the C19RM Fast-track investment channel established under paragraph 5.c of GF/B44/EDP18. The AFC may increase the C19RM Fast-track investment ceiling by up to a further USD 700 million, based on additional funds approved as available by the AFC. </p>
<p>Budgetary implications (included in, or additional to, OPEX budget): No material budget implications are envisioned. Any incremental management and operating costs directly attributable to the proposed expansion of the C19RM’s fast-track ceiling amount will continue to be covered from funds made available for C19RM, pursuant to GF/B44/EDP18.</p>
|
| 2021-08-05 | B45 | GF/B45/EDP13 |
Approval of the Secretariat’s Recommendation on Funding from the COVID-19 Response Mechanism (Burkina Faso, Côte d'Ivoire and Rwanda) Approval of the Secretariat’s Recommendation on Funding from the COVID-19 Response Mechanism (Burkina Faso, Côte d'Ivoire and Rwanda)
<p>The Board:</p>
<ol>
<li>Notes its decision in GF/B44/EDP18, which requires the Secretariat to recommend to the Board, for its approval, any COVID-19 Response Mechanism (“C19RM”) awards exceeding US$35 million, as measured in aggregate by country (not including any funding awarded for COVID-19 commodities through fast-track investments or C19RM funding awarded in 2020);</li>
<li>Approves the funding recommended for each country, as listed in Table 1 of GF/B44/ER10; and</li>
<li>Delegates to the Secretariat authority to redistribute the overall upper-ceiling of funding available for each country among its constituent grants in accordance with the previously approved principles under GF/B44/EDP18. </li>
</ol>
|
| 2021-08-13 | B45 | GF/B45/EDP14 |
Approval of the Secretariat’s Recommendation on Funding from the COVID-19 Response Mechanism (Indonesia and Nigeria) Approval of the Secretariat’s Recommendation on Funding from the COVID-19 Response Mechanism (Indonesia and Nigeria)
<p>The Board:</p>
<ol>
<li>Notes its decision in GF/B44/EDP18, which requires the Secretariat to recommend to the Board, for its approval, any COVID-19 Response Mechanism (“C19RM”) awards exceeding US$35 million, as measured in aggregate by country (not including any funding awarded for COVID-19 commodities through fast-track investments or C19RM funding awarded in 2020);</li>
<li>Approves the funding recommended for each country, as listed in Table 1 of GF/B44/ER13; and</li>
<li>Delegates to the Secretariat authority to redistribute the overall upper-ceiling of funding available for each country among its constituent grants in accordance with the previously approved principles under GF/B44/EDP18.</li>
</ol>
|
| 2021-08-20 | B45 | GF/B45/EDP15 |
Appointment of Replacement Chair of the Strategy Committee Appointment of Replacement Chair of the Strategy Committee
<p>The Board approves the appointment of Carolyn Gomes as Chair of the Strategy Committee for a term that will expire in May 2022, or until the appointment of her successor.</p>
|
| 2021-08-19 | B45 | GF/B45/EDP16 |
Approval of the Secretariat’s Recommendation on Funding from the COVID-19 Response Mechanism (Myanmar and Ukraine) Approval of the Secretariat’s Recommendation on Funding from the COVID-19 Response Mechanism (Myanmar and Ukraine)
<p>The Board:</p>
<ol>
<li>Notes its decision in GF/B44/EDP18, which requires the Secretariat to recommend to the Board, for its approval, any COVID-19 Response Mechanism (“C19RM”) awards exceeding US$35 million, as measured in aggregate by country (not including any funding awarded for COVID-19 commodities through fast-track investments or C19RM funding awarded in 2020);</li>
<li>Approves the funding recommended for each country, as listed in Table 1 of GF/B44/ER15; and</li>
<li>Delegates to the Secretariat authority to redistribute the overall upper-ceiling of funding available for each country among its constituent grants in accordance with the previously approved principles under GF/B44/EDP18. </li>
</ol>
|
| 2021-09-02 | B45 | GF/B45/EDP17 |
Approval of the Secretariat’s Recommendation on Funding from the COVID-19 Response Mechanism (Mali, Mozambique and South Africa) Approval of the Secretariat’s Recommendation on Funding from the COVID-19 Response Mechanism (Mali, Mozambique and South Africa)
<p>The Board:</p>
<ol>
<li>Notes its decision in GF/B44/EDP18, which requires the Secretariat to recommend to the Board, for its approval, any COVID-19 Response Mechanism (“C19RM”) awards exceeding US$35 million, as measured in aggregate by country (not including any funding awarded for COVID-19 commodities through fast-track investments or C19RM funding awarded in 2020);</li>
<li>Approves the funding recommended for each country, as listed in Table 1 of GF/B44/ER16; and</li>
<li>Delegates to the Secretariat authority to redistribute the overall upper-ceiling of funding available for each country among its constituent grants in accordance with the previously approved principles under GF/B44/EDP18.</li>
</ol>
|
| 2021-09-30 | B45 | GF/B45/EDP18 |
Approval of the Secretariat’s Recommendation on Funding from the COVID-19 Response Mechanism (Central African Republic) Approval of the Secretariat’s Recommendation on Funding from the COVID-19 Response Mechanism (Central African Republic)
<p>The Board:</p>
<ol>
<li>Notes its decision in GF/B44/EDP18, which requires the Secretariat to recommend to the Board, for its approval, any COVID-19 Response Mechanism (“C19RM”) awards exceeding US$35 million, as measured in aggregate by country (not including any funding awarded for COVID-19 commodities through fast-track investments or C19RM funding awarded in 2020);</li>
<li>Approves the funding recommended for each country, as listed in Table 1 of GF/B44/ER17; and</li>
<li>Delegates to the Secretariat authority to redistribute the overall upper-ceiling of funding available for each country among its constituent grants in accordance with the previously approved principles under GF/B44/EDP18.</li>
</ol>
|
| 2021-10-04 | B45 | GF/B45/EDP19 |
Appointment of Replacement Members on the Audit and Finance Committee and the Strategy Committee Appointment of Replacement Members on the Audit and Finance Committee and the Strategy Committee
<ol>
<li>The Board approves the appointment of Florence Perez, representing the France Constituency, as a voting member of the Audit and Finance Committee for a term that will expire in May 2022, or until the appointment of her successor.</li>
<li>The Board approves the appointment of Andriy Klepikov, representing the Developing Country NGOs Constituency, as a voting member of the Strategy Committee for a term that will expire in May 2022, or until the appointment of his successor.</li>
<li>The Board approves the appointment of Hampus Holmer, representing the Point 7 Constituency, as a voting member of the Strategy Committee for a term that will expire in May 2022, or until the appointment of his successor</li>
</ol>
|
| 2021-10-12 | B45 | GF/B45/EDP20 |
Approval of the Report of the Global Fund Extraordinary Board Meeting (22 July 2021) Approval of the Report of the Global Fund Extraordinary Board Meeting (22 July 2021)
<p>The Board approves the Report of the Extraordinary Board Meeting, as set forth in GF/EBM01-2021/03.</p>
|
| 2021-10-19 | B45 | GF/B45/EDP21 |
Decision on the Secretariat’s Recommendation on Funding from the 2020-2022 Allocation Decision on the Secretariat’s Recommendation on Funding from the 2020-2022 Allocation
<p>The Board:</p>
<ol>
<li>Approves the funding recommended for each country disease component, and its constituent grants, as listed in Table 1 of GF/B45/ER19 (“Table 1”);</li>
<li>Acknowledges each country disease component’s constituent grants will be implemented by the proposed Principal Recipients listed in Table 1, or any other Principal Recipient(s) deemed appropriate by the Secretariat in accordance with Global Fund policies;</li>
<li>Affirms the funding approved under this decision (a) is subject to the availability of funding, and (b) shall be committed in annual tranches; and</li>
<li>Delegates to the Secretariat authority to redistribute the overall upper-ceiling of funding available for each country disease component among its constituent grants, provided that the Technical Review Panel (the “TRP”) validates any redistribution that constitutes a material change from the program and funding request initially reviewed and recommended by the TRP.</li>
</ol>
|
| 2021-10-19 | B45 | GF/B45/EDP22 |
Decision on the Secretariat’s Recommendation on Additional Funding for the 2020-2022 Allocation Period Decision on the Secretariat’s Recommendation on Additional Funding for the 2020-2022 Allocation Period
<p>The Board:</p>
<ol>
<li>Approves the revised budget recommended for the grant listed in Table 2 of GF/B45/ER19 (“Table 2”);</li>
<li>Affirms the additional funding approved under this decision (a) increases the upper-ceiling amount that may be available for the relevant implementation period of each country disease component’s constituent grants, and (b) is subject to the availability of funding; and</li>
<li>Delegates to the Secretariat authority to redistribute the overall upper-ceiling of funding available for each country disease component among its constituent grants, provided that the Technical Review Panel (the “TRP”) validates any redistribution that constitutes a material change from the program and funding request initially reviewed and recommended by the TRP.</li>
</ol>
|
| 2021-10-19 | B45 | GF/B45/EDP23 |
Decision on the Secretariat’s Recommendation on Grant Extensions Decision on the Secretariat’s Recommendation on Grant Extensions
<p>The Board:</p>
<ol>
<li>Approves the extension budget and revised implementation period recommended for each grant listed in Table 3 of GF/B45/ER02 (“Table 3”);</li>
<li>Affirms that any additional funding provided to fund the extension budget (a) shall increase the upper-ceiling amount that may be available for the relevant implementation period for each grant listed in Table 3, and (b) is subject to the availability of funding.</li>
</ol>
|
| 2021-10-21 | B45 | GF/B45/EDP24 |
Approval of the Secretariat’s Recommendation on Funding from the COVID-19 Response Mechanism (Cameroon and DRC) Approval of the Secretariat’s Recommendation on Funding from the COVID-19 Response Mechanism (Cameroon and DRC)
<p>The Board:</p>
<ol>
<li>Notes its decision in GF/B44/EDP18, which requires the Secretariat to recommend to the Board, for its approval, any COVID-19 Response Mechanism (“C19RM”) awards exceeding US$35 million, as measured in aggregate by country (not including any funding awarded for COVID 19 commodities through fast-track investments or C19RM funding awarded in 2020);</li>
<li>Approves the funding recommended for each country, as listed in Table 1 of GF/B45/ER20; and</li>
<li>Delegates to the Secretariat authority to redistribute the overall upper-ceiling of funding available for each country among its constituent grants in accordance with the previously approved principles under GF/B44/EDP18.</li>
</ol>
|
| 2021-10-19 | B45 | GF/B45/EDP25 |
Extension of terms of the Board Chair and Vice-Chair Extension of terms of the Board Chair and Vice-Chair
<p>In response to the continued exceptional circumstances related to the current Covid-19 pandemic, the Board:</p>
<ol>
<li>Extends its recognition to Dr Donald Kaberuka, Chair of the Board, and Lady Roslyn Morauta, Vice-Chair of the Board, for their service since May 2019;</li>
<li>Thanks the Ethics and Governance Committee for their recommendation and notes the analysis and review process preceding this decision; and</li>
<li>Extends the terms of Dr Donald Kaberuka, as Chair of the Board, and Lady Roslyn Morauta, as Vice-Chair of the Board, to the adjournment of the first Board Meeting in 2023.</li>
</ol>
|
| 2021-11-03 | B45 | GF/B45/EDP26 |
Approval of the Secretariat’s Recommendation on Funding from the COVID-19 Response Mechanism (Russian Federation and Zimbabwe) Approval of the Secretariat’s Recommendation on Funding from the COVID-19 Response Mechanism (Russian Federation and Zimbabwe)
<p>The Board:</p>
<ol>
<li>Notes its decision in GF/B44/EDP18, which requires the Secretariat to recommend to the Board, for its approval, any COVID-19 Response Mechanism (“C19RM”) awards exceeding US$35 million, as measured in aggregate by country (not including any funding awarded for COVID-19 commodities through fast-track investments or C19RM funding awarded in 2020);</li>
<li>Approves the funding recommended for each country, as listed in Table 1 of GF/B44/ER21; and</li>
<li>Delegates to the Secretariat authority to redistribute the overall upper-ceiling of funding available for each country among its constituent grants in accordance with the previously approved principles under GF/B44/EDP18. </li>
</ol>
|
| 2021-11-10 | B45 | GF/B45/EDP27 |
Approval of the Secretariat’s Recommendation on Funding from the COVID-19 Response Mechanism (Indonesia) Approval of the Secretariat’s Recommendation on Funding from the COVID-19 Response Mechanism (Indonesia)
<p>The Board:</p>
<ol>
<li>Notes its decision in GF/B44/EDP18, which requires the Secretariat to recommend to the Board, for its approval, any COVID-19 Response Mechanism (“C19RM”) awards exceeding US$35 million, as measured in aggregate by country (not including any funding awarded for COVID-19 commodities through fast-track investments or C19RM funding awarded in 2020), as well as increases to C19RM awards previously approved by the Board that either exceed USD 10 million or include interventions not previously approved by the Board;</li>
<li>Approves the funding recommended for each country, as listed in Table 1 of GF/B45/ER22; and</li>
<li>Delegates to the Secretariat authority to redistribute the overall upper-ceiling of funding available for each country among its constituent grants in accordance with the previously approved principles under GF/B44/EDP18.</li>
</ol>
|